Expression characteristics of heparanase in colon carcinoma and its close relationship with cyclooxygenase-2 and angiogenesis

Hepato-Gastroenterology

Volumn 57, Issue 104, 2010, Pages 1510-1514

  Wu, Bin Wen ^a   Li, Dong Feng ^a   Ke, Zun Fu ^b   Ma, Dong ^a   Li, You Jia ^a   Gang, Deng ^a   Zheng, Zhi Gang ^a   Zhang, Kai Jun ^a   Zhang, Ying Hua ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiogenesis; Colon carcinoma; Cyclooxygenase 2; Heparanase

Indexed keywords

CD34 ANTIBODY; CYCLOOXYGENASE 2; HEPARANASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GLUCURONIDASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 79952412968     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Baker AB, Groothuis A, Jonas M, et al: Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice. Circ Res. 2009; 104(3):380-387.
2. Shafat I, Barak AB, Postovsky S, et al: Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment. Neoplasia. 2007; 9(11):909-916. (Pubitemid 350086436)
3. Patel VN, Knox SM, Likar KM, et al: Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development. 2007; 134(23):4177-4186.
4. Cohen-Kaplan V, Naroditsky I, Zetser A, et al: Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer. 2008; 123(11):2566-2573.
5. Rivera RS, Nagatsuka H, Siar CH, et al: Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma. Oncol Rep. 2008; 19(3):657-661. (Pubitemid 351330432)
6. Ilan N, Elkin M, Vlodavsky I: Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol. 2006; 38(12):2018-2039. (Pubitemid 44397619)
7. Carli C, Metz CN, Al-Abed Y, et al: Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology. 2009; 150(7):3128-3137.
8. Toomey DP, Murphy JF, Conlon KC: COX-2, VEGF and tumour angiogenesis. Surgeon. 2009; 7(3):174-180.
9. Sato T, Yamaguchi A, Goi T, et al: Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. J Surg Oncol. 2004; 87(4):174-181. (Pubitemid 39167384)
10. Cai YG, Fang DC, Chen L, et al: Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro.Tumour Biol. 2007; 28(4):238-246.
11. Liu Y, Ding YQ, Xin XY, et al: Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29. Ai Zheng. 2005; 24(12):1427-1430.
12. Konno A, Hoshino Y, Terashima S, et al: Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis. 2002; 19(1):61-70. (Pubitemid 34208355)
13. Fukasawa M, Kimura M, Morita S, et al: Microarray analysis of promoter methylation in lung cancers. J Hum Genet. 2006; 51(4):368-374.
14. Okawa T, Naomoto Y, Nobuhisa T, et al: Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res. 2005; 11(22):7995-8005. (Pubitemid 41698740)
15. Rohloff J, Zinke J, Schoppmeyer K, et al: Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer. 2002; 86:1270-1275.
16. Tang W, Nakamura Y, Tsujimoto M, et al: Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol. 2002; 15:593-598. (Pubitemid 34666461)
17. Takaoka M, Naomoto Y, Ohkawa T, et al: Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab Invest. 2003; 83:613-622. (Pubitemid 36618040)
18. Beckhove P, Helmke BM, Ziouta Y, et al: Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Clin Cancer Res. 2005; 11:2899-2906. (Pubitemid 40525191)
19. Amir O, Roy SH: Angiogenesis and lung cancer: implications for prognosis and treatment. The Lancet Oncology 2007; 8:460-461.
20. Kerbel RS: Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000; 21:505-515.
21. Kelly T, Miao HQ, Yang Y, et al: High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res. 2003;63:8749-8756. (Pubitemid 38064053)
22. Watanabe M, Aoki Y, Kase H, et al: Heparanase expression and angiogenesis in endometrial cancer. Gynecol Obstet Invest. 2003; 56:77-82. (Pubitemid 37100224)
23. Cohen I, Pappo O, Elkin M, et al: Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer. 2006; 118:1609-1617. (Pubitemid 43376422)
24. Zetser A, Bashenko Y, Edovitsky E, et al: Heparanase induces VEGF expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 2006; 66:1455-1463. (Pubitemid 43259926)
25. Kobayashi H, Sugihara K, Uetake H, et al: Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis. Int J Oncol. 2009; 34(4):1147-1153.
26. Wu YL, Fu SL, Zhang YP, et al: Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts.Biomed Pharmacother. 2005; 59 Suppl 2:S289-292.